Up-regulation of GPR48 induced by down-regulation of p27Kip1 enhances carcinoma cell invasiveness and metastasis

被引:75
作者
Gao, Yun
Kitagawa, Kyoko
Hiramatsu, Yoshihiro
Kikuchi, Hirotoshi
Isobe, Tomoyasu
Shimada, Mai
Uchida, Chiharu
Hattori, Takayuki
Oda, Toshiaki
Nakayama, Keiko
Nakayama, Keiichi I.
Tanaka, Tatsuo
Konno, Hiroyuki
Kitagawa, Masatoshi
机构
[1] Hamamatsu Univ Sch Med, Dept Biochem 1, Hamamatsu, Shizuoka 4313192, Japan
[2] Hamamatsu Univ Sch Med, Dept Endoscop & Photodynam Med, Hamamatsu, Shizuoka 4313192, Japan
[3] Hamamatsu Univ Sch Med, Dept Surg 2, Hamamatsu, Shizuoka 4313192, Japan
[4] Hamamatsu Univ Sch Med, Dept Oral & Maxillofacial Surg, Hamamatsu, Shizuoka 4313192, Japan
[5] Tohoku Univ, Grad Sch Med, Div Dev Genet, Ctr Translat & Adv Anim Res Human Dis, Sendai, Miyagi 980, Japan
[6] Kyushu Univ, Dept Mol & Cellular Biol, Med Inst Bioregulat, Higashi Ku, Fukuoka 812, Japan
关键词
D O I
10.1158/0008-5472.CAN-06-2629
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A reduced expression level of the cyclin-dependent kinase inhibitor P27(Kip1) is associated with increased tumor malignancy and poor prognosis in individuals with various types of cancer. To investigate the basis for this relation, we applied microarray analysis to screen for genes differentially expressed between p27(+/-) and parental (p27(+/+)) HCT116 human colon carcinoma cells. Expression of the gene for G protein-coupled receptor 48 (GPR48) was increased in the p27(+/-) cells. Forced expression of GPR48 increased both in vitro invasive activity and lung metastasis potency of HCT116 cells. In contrast, depletion of endogenous GPR48 by RNA interference reduced the invasive potential of HeLa and Lewis lung carcinoma cells not only in vitro but also in vivo. Moreover, GPR48 expression was significantly associated with lymph node metastasis and inversely correlated with p27 expression in human colon carcinomas. GPR48 may thus play an important role in invasiveness and metastasis of carcinoma and might therefore represent a potential prognostic marker or therapeutic target.
引用
收藏
页码:11623 / 11631
页数:9
相关论文
共 37 条
[1]   p27Kip1-stathmin interaction influences sarcoma cell migration and invasion [J].
Baldassarre, G ;
Belletti, B ;
Nicoloso, MS ;
Schiappacassi, M ;
Vecchione, A ;
Spessotto, P ;
Morrione, A ;
Canzonieri, V ;
Colombatti, A .
CANCER CELL, 2005, 7 (01) :51-63
[2]   p27Kip1 modulates cell migration through the regulation of RhoA activation [J].
Besson, A ;
Gurian-West, M ;
Schmidt, A ;
Hall, A ;
Roberts, JM .
GENES & DEVELOPMENT, 2004, 18 (08) :862-876
[3]   Small GTP-binding protein-coupled receptors [J].
Bhattacharya, M ;
Babwah, AV ;
Ferguson, SSG .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2004, 32 :1040-1044
[4]   Deregulated degradation of the cdk inhibitor p27 and malignant transformation [J].
Bloom, J ;
Pagano, M .
SEMINARS IN CANCER BIOLOGY, 2003, 13 (01) :41-47
[5]   Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase [J].
Bornstein, G ;
Bloom, J ;
Sitry-Shevah, D ;
Nakayama, K ;
Pagano, M ;
Hershko, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (28) :25752-25757
[6]   Recent advances in drug action and therapeutics: Relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology [J].
Brink, CB ;
Harvey, BH ;
Bodenstein, J ;
Venter, DP ;
Oliver, DW .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (04) :373-387
[7]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[8]   Decreased levels of the cell-cycle inhibitor p27(Kip1) protein: Prognostic implications in primary breast cancer [J].
Catzavelos, C ;
Bhatacharya, N ;
Ung, YC ;
Wilson, JA ;
Roncari, L ;
Sandhu, C ;
Shaw, P ;
Yeger, H ;
MoravaProtzner, I ;
Kapusta, L ;
Franssen, E ;
Pritchard, KI ;
Slingerland, JM .
NATURE MEDICINE, 1997, 3 (02) :227-230
[9]   The Rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1 [J].
Daniel, C ;
Pippin, J ;
Shankland, SJ ;
Hugo, C .
LABORATORY INVESTIGATION, 2004, 84 (05) :588-596
[10]  
Dhanasekaran N., 1995, Endocrine Reviews, V16, P259